221 related articles for article (PubMed ID: 22353935)
1. Overexpression of centrosomal protein Nlp confers breast carcinoma resistance to paclitaxel.
Zhao W; Song Y; Xu B; Zhan Q
Cancer Biol Ther; 2012 Feb; 13(3):156-63. PubMed ID: 22353935
[TBL] [Abstract][Full Text] [Related]
2. Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.
Casenghi M; Meraldi P; Weinhart U; Duncan PI; Körner R; Nigg EA
Dev Cell; 2003 Jul; 5(1):113-25. PubMed ID: 12852856
[TBL] [Abstract][Full Text] [Related]
3. Cdc2/cyclin B1 regulates centrosomal Nlp proteolysis and subcellular localization.
Zhao X; Jin S; Song Y; Zhan Q
Cancer Biol Ther; 2010 Nov; 10(9):945-52. PubMed ID: 20890132
[TBL] [Abstract][Full Text] [Related]
4. Rational combinations of siRNAs targeting Plk1 with breast cancer drugs.
Spänkuch B; Kurunci-Csacsko E; Kaufmann M; Strebhardt K
Oncogene; 2007 Aug; 26(39):5793-807. PubMed ID: 17369857
[TBL] [Abstract][Full Text] [Related]
5. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of Nlp, a potential oncogene in ovarian cancer, and its implication in carcinogenesis.
Qu D; Qu H; Fu M; Zhao X; Liu R; Sui L; Zhan Q
Gynecol Oncol; 2008 Aug; 110(2):230-6. PubMed ID: 18538832
[TBL] [Abstract][Full Text] [Related]
7. End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability.
Luo Y; Li D; Ran J; Yan B; Chen J; Dong X; Liu Z; Liu R; Zhou J; Liu M
Protein Cell; 2014 Jun; 5(6):469-79. PubMed ID: 24748116
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
Wang S; Huang X; Lee CK; Liu B
Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells.
Ajabnoor GM; Crook T; Coley HM
Cell Death Dis; 2012 Jan; 3(1):e260. PubMed ID: 22278287
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
[TBL] [Abstract][Full Text] [Related]
12. Centrosomal Protein 70 Is a Mediator of Paclitaxel Sensitivity.
Shi X; Wang Y; Sun X; Wang C; Jiang P; Zhang Y; Huang Q; Liu X; Li D; Zhou J; Liu M
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632150
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of Nlp by Plk1 negatively regulates its dynein-dynactin-dependent targeting to the centrosome.
Casenghi M; Barr FA; Nigg EA
J Cell Sci; 2005 Nov; 118(Pt 21):5101-8. PubMed ID: 16254247
[TBL] [Abstract][Full Text] [Related]
14. Preferential Killing of Tetraploid Colon Cancer Cells by Targeting the Mitotic Kinase PLK1.
Jemaà M; Kifagi C; Serrano SS; Massoumi R
Cell Physiol Biochem; 2020 Apr; 54(2):303-320. PubMed ID: 32259417
[TBL] [Abstract][Full Text] [Related]
15. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
[TBL] [Abstract][Full Text] [Related]
16. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
Spänkuch B; Heim S; Kurunci-Csacsko E; Lindenau C; Yuan J; Kaufmann M; Strebhardt K
Cancer Res; 2006 Jun; 66(11):5836-46. PubMed ID: 16740723
[TBL] [Abstract][Full Text] [Related]
18. ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells.
Thollet A; Vendrell JA; Payen L; Ghayad SE; Ben Larbi S; Grisard E; Collins C; Villedieu M; Cohen PA
Mol Cancer; 2010 Nov; 9():291. PubMed ID: 21059223
[TBL] [Abstract][Full Text] [Related]
19. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
Choi YH; Yoo YH
Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
[TBL] [Abstract][Full Text] [Related]
20. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
